6CM
RDHL

683 Capital Management’s Redhill Biopharma RDHL Stock Holding History

683 Capital Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,035
Closed -$6.28M – 184
2019
Q4 		$6.28M Sell
1,035
-2,441
-70% -$15.6M 1% 33
2019
Q3 		$24.5M Sell
3,476
-218
-6% -$1.59M 4.07% 8
2019
Q2 		$24M Hold
3,694
– – 3.13% 10
2019
Q1 		$30.7M Hold
3,694
– – 4.12% 6
2018
Q4 		$20.5M Buy
3,694
+63
+2% +$483K 3.05% 17
2018
Q3 		$32.1M Buy
3,631
+1,588
+78% +$12.9M 3.99% 10
2018
Q2 		$17.4M Buy
2,043
+379
+23% +$2.41M 2.27% 20
2018
Q1 		$8.57M Buy
1,664
+665
+67% +$3.83M 1.27% 38
2017
Q4 		$5.14M Buy
+999
New +$6.73M 0.82% 63

Other funds holding RDHL

II
Ibex Investors Denver, Colorado $146M AUM 19.17% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return